Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1989-05-25
1992-09-08
Kepplinger, Esther L.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
436504, 436804, 436813, G01N 33574
Patent
active
051457733
ABSTRACT:
This invention provides a method of detecting sensitivity to alpha-interferon therapy which comprises contacting a sample with a monoclonal antibody under conditions so as to form an antibody-antigen complex, detecting the complex so formed, and thereby detecting sensitivity to alpha-interferon.
REFERENCES:
patent: 4713352 (1987-12-01), Bander et al.
Nanus et al "Absence of gp 160 Expression in Renal Carcinomas Predicts Sensitivity to Alpha-Interferon," Proceedings of the American Assoc. for Cancer Research vol. 3, Mar. 1989 Abstract 1546 p. 389.
Quesada et al "Renal Cell Carcinoma: Antitumor Effects of Leukocyte Interferon" Cancer Research vol. 43 (Feb. 1983) pp. 940-947.
Albino Anthony P.
Bander Neil H.
Nanus David M.
Pfeffer Lawrence M.
Bidwell Carol E.
Kepplinger Esther L.
Sloan-Kettering Institute for Cancer Research
White John P.
LandOfFree
Method to detect sensitivity to alpha-interferon therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method to detect sensitivity to alpha-interferon therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to detect sensitivity to alpha-interferon therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-133646